(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202512 | 202412 | % Var | 202512 | 202412 | % Var | 202503 | 202403 | % Var | |
| Sales | 3.82 | 0.00 | 0.00 | 7.04 | 8.22 | -14.36 | 8.13 | 10.39 | -21.75 |
| Other Income | 0.18 | 0.00 | 0.00 | 0.40 | 0.28 | 42.86 | 0.00 | 0.14 | 0.00 |
| PBIDT | 0.94 | -0.41 | -329.27 | 0.53 | 1.22 | -56.56 | 0.99 | 0.63 | 57.14 |
| Interest | 0.01 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.01 | 0.04 | -75.00 |
| PBDT | 0.93 | -0.41 | -326.83 | 0.51 | 1.22 | -58.20 | 0.98 | 0.59 | 66.10 |
| Depreciation | 0.12 | 0.00 | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 | 0.07 | -100.00 |
| PBT | 0.81 | -0.41 | -297.56 | 0.35 | 1.22 | -71.31 | 0.98 | 0.52 | 88.46 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 | -0.04 | -25.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 | -0.04 | -25.00 |
| PAT | 0.81 | -0.41 | -297.56 | 0.35 | 1.22 | -71.31 | 1.01 | 0.56 | 80.36 |
| Equity | 20.50 | 20.50 | 0.00 | 20.50 | 20.50 | 0.00 | 20.50 | 20.50 | 0.00 |
| PBIDTM(%) | 24.61 | 0.00 | 0.00 | 7.53 | 14.84 | -49.28 | 12.18 | 6.06 | 100.83 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: